Login / Signup

Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum.

Lutfiye Ozlem AtayEsen SakaÜmit Özgür AkdemirEzgi YetimErdem BalcıEthem Murat ArsavaMehmet Akif Topcuoglu
Published in: Current Alzheimer research (2023)
Integrated use of structural, metabolic, molecular (Aβ) and perfusion (CBF) parameters contribute to the discrimination of SCD, aMCI, and ADD.
Keyphrases
  • contrast enhanced
  • pet ct
  • positron emission tomography
  • pet imaging
  • computed tomography
  • magnetic resonance imaging
  • cognitive decline
  • diffusion weighted imaging